| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 03/24/2011 | US20110071084 Benzazepine derivatives useful as vasopressin antagonists |
| 03/24/2011 | US20110070297 Glucokinase activators |
| 03/24/2011 | US20110070197 Hepatitis c virus inhibitors |
| 03/24/2011 | US20110070193 Anti-Infective Agents and Uses Thereof |
| 03/24/2011 | US20110070189 Heterocyclic antiviral compounds |
| 03/24/2011 | CA2774515A1 Substituted phenylamine carboxamide analogs as mglur5 negative allosteric modulators and methods of making and using the same |
| 03/24/2011 | CA2774374A1 Substituted benzamide analogs as mglur5 negative allosteric modulators and methods of making and using the same |
| 03/24/2011 | CA2774372A1 Substituted heteroarylamine carboxamide analogs as mglur5 negative allosteric modulators and methods of making and using the same |
| 03/24/2011 | CA2774239A1 Treatment for oxidative stress and/or hypertension |
| 03/24/2011 | CA2774145A1 Hcv protease inhibitors |
| 03/24/2011 | CA2774018A1 Process for preparing 3-[(4s)-8-bromo-1-methyl-6-(2-pyridinyl)-4h-imidazo[1,2-a][1,4]benzodiazepine-4-yl]propionic acid methyl ester or the benzene sulfonate salt thereof, and compounds useful in that process |
| 03/24/2011 | CA2773985A1 Protein kinase conjugates and inhibitors |
| 03/24/2011 | CA2773832A1 Compounds useful against kinetoplastideae parasites |
| 03/24/2011 | CA2772689A1 Glycine compound |
| 03/24/2011 | CA2772674A1 Alkene oxindole derivatives and their uses to treat obesity, diabetes and hyperlipidemia |
| 03/24/2011 | CA2771612A1 Selective calcium channel modulators |
| 03/24/2011 | CA2770932A1 Substituted n-phenyl-1-(4-pyridinyl)-1h-pyrazol-3-amines |
| 03/24/2011 | CA2768924A1 Heterocyclic antiviral compounds |
| 03/23/2011 | EP2299510A1 Organic electroluminescent element |
| 03/23/2011 | EP2298828A1 Polymeric compound containing metal complex residue and element comprising same |
| 03/23/2011 | EP2298770A1 Heterocyclic compounds as TrkA modulators |
| 03/23/2011 | EP2298761A1 HIV inhibiting pyrimidines derivatives |
| 03/23/2011 | EP2298760A1 Crystal forms of (3R)-1-(2-methylalanyl-D-tryptophyl)-3-(phenylmethyl)-3-piperidinecarboxylic acid 1,2,2-trimethylhydrazide |
| 03/23/2011 | EP2298759A1 Anabaseine derivatives useful in the treatment of neurodegenerative diseases |
| 03/23/2011 | EP2298758A1 Anabaseine derivatives useful in the treatment of neurodegenerative diseases |
| 03/23/2011 | EP2298757A2 Urea compounds active as vanilloid receptor antagonist for the treatment of pain |
| 03/23/2011 | EP2298748A2 Triazole compounds that modulate HSP90 activity |
| 03/23/2011 | EP2298747A1 Triazole derivative or salt thereof |
| 03/23/2011 | EP2298746A1 4-amino- quinazoline and quinoline derivatives having an inhibitory effect on signal transduction mediated by tyrosine kinases |
| 03/23/2011 | EP2298743A1 5-membered heterocycle-based P38 kinase inhibitors |
| 03/23/2011 | EP2298739A1 Organic light emitting device containing polycyclic heteroaryl compounds |
| 03/23/2011 | EP2298736A1 Hydrazine-based and carbonyl-based bifunctional crosslinking reagents |
| 03/23/2011 | EP2298734A2 Cyclobutyl amine derivatives |
| 03/23/2011 | EP2298332A1 BAFF, inhibitors thereof and their use in the modulation of the B-cell response |
| 03/23/2011 | EP2298311A1 w-Carboxy aryl substituted diphenyl ureas as p38 kinase inhibitors |
| 03/23/2011 | EP2298305A1 4-(N-Phenylamino)-quinazolines/quinolines as inhibitors of tyrosine kinases |
| 03/23/2011 | EP2298300A1 Compositions for inhibition of anglogenesis comprising thalidomide and aspirin |
| 03/23/2011 | EP2298283A2 Pharmaceutical formulations comprising cannabinoids |
| 03/23/2011 | EP2297142A1 Novel substituted pyridin-2-ones and pyridazin-3-ones |
| 03/23/2011 | EP2297137A1 Novel heteroaryl carboxamide derivatives |
| 03/23/2011 | EP2297136A2 Insecticidal pyridylpiperidine compounds |
| 03/23/2011 | EP2297135A1 Process for the preparation of an orexin receptor antagonist |
| 03/23/2011 | EP2297134A1 Substituted pyridin-4 -yl-methyl sulfonamides as fungicides |
| 03/23/2011 | EP2297133A1 1, 2 disubstituted heterocyclic compounds |
| 03/23/2011 | EP2297132A1 Method for producing an intermediate product of dabigatran etexilate |
| 03/23/2011 | EP2297131A2 Di-substituted phenyl compounds as phosphodiesterase 10 inhibitors |
| 03/23/2011 | EP2297130A1 Novel heteroaromatic amides and thioamides as pesticides |
| 03/23/2011 | EP2297129A1 Substituted cyclopropyl compounds, compositions containing such compounds and methods of treatment |
| 03/23/2011 | EP2297118A1 N- (1, 1, 1, 3, 3, 3-hexafluoro-2-hydroxypropan-2-yl) benzyl-n' -arylcarbonylpiperaz ine derivatives |
| 03/23/2011 | EP2297117A1 Bicyclic heterocycle derivatives and use thereof as gpr119 modulators |
| 03/23/2011 | EP2297114A2 Heterocyclic compound and use thereof |
| 03/23/2011 | EP2297112A1 Pyrazole compounds as ccr1 antagonists |
| 03/23/2011 | EP2297106A1 Phenoxypyridinylamide derivatives and their use in the treatment of pde4 mediated disease states |
| 03/23/2011 | EP2297102A1 Heteroaromatic monoamides as orexinin receptor antagonists |
| 03/23/2011 | EP2297100A1 Tetrahydrocyclopentaýb¨indole androgen receptor modulators |
| 03/23/2011 | EP2297098A1 Pyrrolidine derivatives as nk2 receptor antagonists |
| 03/23/2011 | EP2297097A2 Compounds and compositions useful for the treatment of malaria |
| 03/23/2011 | EP2297096A2 Aryl ketone as mri |
| 03/23/2011 | EP2296653A1 Compounds and methods for treating inflammatory and fibrotic disorders |
| 03/23/2011 | EP2229358B1 Indoles and their therapeutic use |
| 03/23/2011 | EP2205589B1 C-met protein kinase inhibitors |
| 03/23/2011 | EP2203440B1 Inhibitors of the interaction between mdm2 and p53 |
| 03/23/2011 | EP2109608B1 Amide substituted indazoles as poly(adp-ribose)polymerase (parp) inhibitors |
| 03/23/2011 | EP2076260B1 N-methylaminomethyl isoindole compounds and compositions comprising and methods of using the same |
| 03/23/2011 | EP1888565B1 2, 6-di (hetero) aryl -4-amido-pyrimidines as adenosine receptor antagonists |
| 03/23/2011 | EP1140836B1 Amide compounds |
| 03/23/2011 | CN1942436B Lysine based compounds |
| 03/23/2011 | CN101990538A C-met protein kinase inhibitors |
| 03/23/2011 | CN101990537A Amide derivatives as positive allosteric modulators and methods of use thereof |
| 03/23/2011 | CN101990536A Pyrollidine-based compounds |
| 03/23/2011 | CN101987847A Novel heterocyclic NF-kB inhibitors |
| 03/23/2011 | CN101987843A Method for synthesizing halofuginone hydrobromide and analogues thereof |
| 03/23/2011 | CN101987832A Preparation method of 2-trifluoromethyl indole derivatives |
| 03/23/2011 | CN101024660B Peroxo vanadium complex and its preparing method and crystal culture |
| 03/23/2011 | CN101024653B 2-peroxo-vanadium-potassium salt complex, its preparing method and mono-crystal culture |
| 03/22/2011 | US7910743 Compounds, compositions and methods |
| 03/22/2011 | US7910742 Survivin inhibitors |
| 03/22/2011 | US7910739 tacrine derivatives such as N-[5(6-Chloro-1,2,3,4-tetrahydro-acridin-9-ylamino)pentyl]-3-(1H-indol-3-yl) propionamide, used for treatment of neurodegenerative diseases; bioassays |
| 03/22/2011 | US7910731 Bicyclic heterocyclic compounds, pharmaceutical compositions containing these compounds, their use and process for preparing them |
| 03/22/2011 | US7910606 Pyrazole-derivatives as factor Xa inhibitors |
| 03/22/2011 | US7910598 Phenylaminopyrimidine derivatives as inhibitors of BCR-ABL kinase |
| 03/22/2011 | US7910592 CETP inhibitors |
| 03/22/2011 | US7910591 e.g. 3-[4-(4-Pyridine-2-yl-piperazine-1-yl)-butyl]-1,3-dihydro-2H-indol-2-one; serotonin 5-HT7 and alpha 1 receptors modulator; antxiolytic agent, antidepressant; neurodegenerative diseases; schizophrenia, Alzheimer's disease, stroke, dementias; side effect reduction |
| 03/22/2011 | US7910590 Cyclic amine bace-1 inhibitors having a heterocyclic substituent |
| 03/22/2011 | US7910589 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
| 03/22/2011 | US7910588 5-HT7 receptor antagonists |
| 03/22/2011 | US7910586 Drug screening; administering secretase inhibitor; Alzheimer's disease |
| 03/22/2011 | US7910585 Pyrimidine derivatives |
| 03/22/2011 | US7910576 Pyrrole derivatives as P2Y12 antagonists |
| 03/22/2011 | US7910059 For the determination of an analyte or analytes such as proteins, peptides, nucleic acids, carbohydrates, lipids, steroids and small molecules by mass analysis |
| 03/22/2011 | US7908735 Method and installation means for installing an electrical machine |
| 03/22/2011 | CA2632771C Substituted imidazoles and their use as pesticides |
| 03/22/2011 | CA2632091C Crystal forms of 6-[(4-chloro-phenyl)-hydroxy-(3-methyl-3h-imidazol-4-yl)-methyl]-4-(3-ethynyl-phenyl)-1-methyl-1h-quinolin-2-one, 2,3-dihydroxybutanedioate salts and method of production |
| 03/22/2011 | CA2513102C Substituted pyrazoles, compositions containing such compounds and methods of use |
| 03/22/2011 | CA2498091C Sulfonylamino-acetic acid derivatives |
| 03/22/2011 | CA2480880C Inhibitors of akt activity |
| 03/22/2011 | CA2478229C Pyridinoylpiperidines as 5-ht1f agonists |
| 03/22/2011 | CA2445333C Quinoline derivatives and quinazoline derivatives having azolyl group |
| 03/22/2011 | CA2433603C Kappa opioid receptor ligands |
| 03/22/2011 | CA2432572C Oxybenzamides derivatives as factor xa inhibitors |